glp-1 drugs and menopause Microdosing for Perimenopause Menopause: A Hormone-Aware Metabolic Framework GLP-1s and the Menopause: What

Safety, efficacy, and cardiovascular benefits of combination therapy with SGLT-2 inhibitors and GLP-1 receptor agonists in patients with diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials

Low-grade chronic inflammation is now known to be a major contributor to a myriad of conditions, including cancer, obesity and diabetes (Underwerth)

To prolong the half-life of Exenatide, a water in oil in oil (W/O/O) method was employed to prepare exenatide-loaded PLGA microspheres

The HIF-2/PPAR pathway is essential for liraglutide-alleviated, lipid-induced hepatic steatosis

7c, d) in hTRPV1-expressing CHO K1 cells, whereas 1 M BCTC completely blocked these currents